NASDAQ / LIVE COMPANY INTELLIGENCE

Kestra Medical Technologies, Ltd.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERKMTS
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / KMTS COVERAGE

What’s moving Kestra Medical Technologies, Ltd. now

Current reporting with the operating signal separated from the noise.

01
Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial Results

Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial Results

The story matters when it changes Kestra Medical Technologies, Ltd.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Kestra Medical Technologies, Ltd. (KMTS) Q3 2026 Earnings Call Transcript

Kestra Medical Technologies, Ltd. (KMTS) Q3 2026 Earnings Call Transcript

Investors are testing whether Kestra Medical Technologies, Ltd.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
03
Kestra Medical Technologies, Ltd. (KMTS) Q1 2026 Earnings Call Transcript

Kestra Medical Technologies, Ltd. (KMTS) Q1 2026 Earnings Call Transcript

Investors are testing whether Kestra Medical Technologies, Ltd.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
04
Kestra Medical Technologies, Ltd. to Report Third Quarter Fiscal 2025 Financial Results on April 14

Kestra Medical Technologies, Ltd. to Report Third Quarter Fiscal 2025 Financial Results on April 14

The story matters when it changes Kestra Medical Technologies, Ltd.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
05
Kestra Medical Technologies, Ltd. Announces Full Exercise and Closing of Underwriters' Over-Allotment Option in Initial Public Offering

Kestra Medical Technologies, Ltd. Announces Full Exercise and Closing of Underwriters' Over-Allotment Option in Initial Public Offering

The story matters when it changes Kestra Medical Technologies, Ltd.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest KMTS filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-03-17 · Period 2026-01-31SEC ↗10-QQuarterly financial reportFiled 2025-12-11 · Period 2025-10-31SEC ↗10-KAnnual financial reportFiled 2026-07-14 · Period 2026-04-30SEC ↗8-KMaterial company eventFiled 2026-07-14 · Period 2026-07-10SEC ↗8-KMaterial company eventFiled 2026-03-17 · Period 2026-03-17SEC ↗8-KMaterial company eventFiled 2025-12-11 · Period 2025-12-11SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-07-28 · Period 2026-09-09SEC ↗144Official SEC filingFiled 2026-08-04SEC ↗
EARNINGS / QUARTERLY TRACKER

Kestra Medical Technologies, Ltd., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.